These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30315345)

  • 1. Burden of illness of follicular lymphoma and marginal zone lymphoma.
    Monga N; Nastoupil L; Garside J; Quigley J; Hudson M; O'Donovan P; Parisi L; Tapprich C; Thieblemont C
    Ann Hematol; 2019 Jan; 98(1):175-183. PubMed ID: 30315345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada.
    Kuruvilla J; Ewara EM; Elia-Pacitti J; Ng R; Eberg M; Kukaswadia A; Sharma A
    Curr Oncol; 2023 Apr; 30(5):4663-4676. PubMed ID: 37232810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population-based analysis.
    Florindez JA; Chihara D; Reis IM; Lossos IS; Alderuccio JP
    Blood Adv; 2024 Aug; 8(16):4423-4432. PubMed ID: 38954843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of non-hodgkins's lymphoma with a "nodular" growth variant: a clinicopathologic study of follicular, mantle cell and marginal zone lymphomas prospectively diagnosed with multiparameter analyses.
    Kadowaki I; Ichinohasama R; Sasaki O; Kimura J; Kameoka JI; Meguro K; Endo K; Tobinai K; Sasaki T; Sawai T; Ooya K
    Leuk Lymphoma; 1998 Oct; 31(3-4):393-403. PubMed ID: 9869204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews.
    Monga N; Garside J; Gurung B; Quigley J; O'Donovan P; Tapprich C; Nastoupil L; Thieblemont C; Loefgren C
    Pharmacoecon Open; 2020 Dec; 4(4):575-591. PubMed ID: 32200522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma.
    Alhaj Moustafa M; Peterson J; Hoppe BS; Jiang J; Wiseman GA; Witzig TE; Tun HW
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):618-625. PubMed ID: 35400611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marginal zone B-cell lymphoma: a retrospective immunophenotypic analysis.
    Kost CB; Holden JT; Mann KP
    Cytometry B Clin Cytom; 2008 Sep; 74(5):282-6. PubMed ID: 18500740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
    Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
    Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of marginal zone lymphoma (and association with other lymphomas).
    Casulo C; Friedberg J
    Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
    Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
    Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
    Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
    Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
    Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine indolent nodular lymphoma.
    Valli VE; Vernau W; de Lorimier LP; Graham PS; Moore PF
    Vet Pathol; 2006 May; 43(3):241-56. PubMed ID: 16672571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal Zone Lymphoma: State-of-the-Art Treatment.
    Sindel A; Al-Juhaishi T; Yazbeck V
    Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lymphoma and marginal zone lymphoma: how many diseases?
    Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma.
    Dyhdalo KS; Lanigan C; Tubbs RR; Cook JR
    Am J Clin Pathol; 2013 Aug; 140(2):149-54. PubMed ID: 23897248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics.
    Muneishi M; Nakamura A; Tachibana K; Suemitsu J; Hasebe S; Takeuchi K; Yakushijin Y
    Int J Clin Oncol; 2018 Apr; 23(2):375-381. PubMed ID: 29063983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
    Andorsky DJ; Kolibaba KS; Assouline S; Forero-Torres A; Jones V; Klein LM; Patel-Donnelly D; Smith M; Ye W; Shi W; Yasenchak CA; Sharman JP
    Br J Haematol; 2019 Jan; 184(2):215-222. PubMed ID: 30183069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.